Key Highlights
•
A new study of 162 patients found that interstitial lung disease (ILD) linked to certain autoimmune antibodies often has a severe scarring pattern, and lower lung function at diagnosis predicts worse outcomes. This underscores the need for early identification and personalized treatment to preserve lung health in these patients.
Source →
•
A large study of over 2,200 patients with cardiac amyloidosis reveals that nearly 40% have reduced heart pumping function, not just the preserved function typically associated with the disease. Integrating multiple heart imaging measurements provides a much clearer picture of a patient’s prognosis, arguing for a more comprehensive diagnostic approach.
Source →
•
A phase 1 study shows that a reduced-dose regimen of the COVID-19 antiviral nirmatrelvir/ritonavir is safe and achieves effective drug levels in patients with severe kidney impairment, including those on dialysis. This provides a much-needed treatment option for a high-risk population that was previously excluded from standard dosing.
Source →
•
A systematic review finds that corticosteroid injections may offer short-term pain relief for some musculoskeletal conditions in children, but the supporting evidence is of very low quality due to small, varied studies. This highlights a significant gap in research and the urgent need for larger, high-quality trials to establish safe and effective guidelines for pediatric pain management.
Source →
•
A national survey from 2019-2023 indicates that children exposed to neighborhood violence are significantly more likely to face barriers to healthcare, including skipping dental checkups and delaying care due to cost. As challenges to access persist, the findings point to the critical need for policy strategies that ensure robust health coverage for vulnerable children.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
